ArticleJournal of the American Heart Association2024

Pivotal Trials Testing the Efficacy of Novel Anticoagulants for Preventing Emerging Cardioembolic Risk Entities.

Rolf Wachter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.